DK227487A - Substituerede heterocycliske forbindelser - Google Patents
Substituerede heterocycliske forbindelserInfo
- Publication number
- DK227487A DK227487A DK227487A DK227487A DK227487A DK 227487 A DK227487 A DK 227487A DK 227487 A DK227487 A DK 227487A DK 227487 A DK227487 A DK 227487A DK 227487 A DK227487 A DK 227487A
- Authority
- DK
- Denmark
- Prior art keywords
- substituted heterocyclic
- heterocyclic compounds
- compounds
- substituted
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868610909A GB8610909D0 (en) | 1986-05-03 | 1986-05-03 | Compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK227487D0 DK227487D0 (da) | 1987-05-04 |
| DK227487A true DK227487A (da) | 1987-11-04 |
Family
ID=10597340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK227487A DK227487A (da) | 1986-05-03 | 1987-05-04 | Substituerede heterocycliske forbindelser |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4861789A (es) |
| EP (1) | EP0251453B1 (es) |
| JP (1) | JPS62267270A (es) |
| AU (1) | AU600939B2 (es) |
| DE (1) | DE3767789D1 (es) |
| DK (1) | DK227487A (es) |
| ES (1) | ES2031890T3 (es) |
| GB (1) | GB8610909D0 (es) |
| GR (1) | GR3001416T3 (es) |
| NZ (1) | NZ220179A (es) |
| PT (1) | PT84818B (es) |
| ZA (1) | ZA873169B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034406A (en) * | 1989-09-26 | 1991-07-23 | Allergan, Inc. | Method for reducing or maintaining intraocular pressure |
| US5066664A (en) * | 1990-02-28 | 1991-11-19 | Allergan, Inc. | 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents |
| DK148292D0 (da) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Forbindelser |
| US5580892A (en) * | 1993-10-22 | 1996-12-03 | Allergan | Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents |
| WO1996001813A1 (en) * | 1994-07-11 | 1996-01-25 | Allergan | CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| US6150389A (en) | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
| DE19514579A1 (de) | 1995-04-20 | 1996-10-24 | Boehringer Ingelheim Kg | Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz |
| US5677321A (en) | 1996-02-29 | 1997-10-14 | Synaptic Pharmaceutical Corporation | 5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligands |
| WO2007093292A2 (en) * | 2006-02-15 | 2007-08-23 | Bayer Cropscience Ag | Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| EP1988080A1 (en) * | 2007-05-03 | 2008-11-05 | Bayer CropScience AG | Insecticidal substituted 2-aminoindanes |
| WO2008145615A2 (en) * | 2007-05-25 | 2008-12-04 | Basf Se | Aminoazoline and urea derivatives for combating animal pests |
| WO2009023758A1 (en) * | 2007-08-15 | 2009-02-19 | Allergan, Inc. | Heterocyclyl substituted fused carbocyles useful in the treatment of conditions such as glaucoma and pain |
| CA2696314C (en) * | 2007-08-15 | 2016-01-19 | Allergan, Inc. | Therapeutic compounds |
| CA2696404A1 (en) * | 2007-08-15 | 2009-02-19 | Allergan, Inc. | Therapeutic compounds |
| EP2240468B1 (en) * | 2008-01-18 | 2013-10-16 | Allergan, Inc. | Selective subtype alpha 2 adrenergic agents and methods for use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2870161A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | 2-(1-indanyl amino)-oxazolines |
| US2870159A (en) * | 1957-07-08 | 1959-01-20 | Pfizer & Co C | Hydrogenated 2-(1-naphthylamino)-oxazolines |
| US2883410A (en) * | 1957-07-08 | 1959-04-21 | Pfizer & Co C | N-(1-indanyl)-n'-(beta-substituted ethyl)-ureas |
| DE1195323B (de) * | 1963-06-24 | 1965-06-24 | Thomae Gmbh Dr K | Verfahren zur Herstellung von 2-[5', 6', 7', 8'-Tetrahydronaphthyl-(1')-amino]-imidazolin und seinen Salzen |
| US3432600A (en) * | 1963-09-30 | 1969-03-11 | Du Pont | Partially reduced 2-(1-napthylamino) oxazoline,indanylethylureas,and indanylaminooxazoline |
| US3679798A (en) * | 1964-02-28 | 1972-07-25 | Du Pont | Composition comprising arylaminooxazoline and antichloligeneric agent |
| DE1670751A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen |
| DE1670753A1 (de) * | 1966-09-27 | 1970-07-16 | Bayer Ag | Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen |
| US3882229A (en) * | 1972-07-21 | 1975-05-06 | Nordmark Werke Gmbh | Composition and method for shrinking mucous membranes |
| JPS54151990A (en) * | 1978-04-17 | 1979-11-29 | Beiersdorf Ag | Novel condensated nitrogenncontained heterocyclic compound and its manufacture |
-
1986
- 1986-05-03 GB GB868610909A patent/GB8610909D0/en active Pending
-
1987
- 1987-05-04 NZ NZ220179A patent/NZ220179A/xx unknown
- 1987-05-04 DK DK227487A patent/DK227487A/da not_active Application Discontinuation
- 1987-05-04 ZA ZA873169A patent/ZA873169B/xx unknown
- 1987-05-04 US US07/047,720 patent/US4861789A/en not_active Expired - Fee Related
- 1987-05-04 AU AU72479/87A patent/AU600939B2/en not_active Ceased
- 1987-05-04 PT PT84818A patent/PT84818B/pt not_active IP Right Cessation
- 1987-05-05 EP EP87304019A patent/EP0251453B1/en not_active Expired - Lifetime
- 1987-05-05 ES ES198787304019T patent/ES2031890T3/es not_active Expired - Lifetime
- 1987-05-05 DE DE8787304019T patent/DE3767789D1/de not_active Expired - Fee Related
- 1987-05-06 JP JP62110422A patent/JPS62267270A/ja active Pending
-
1991
- 1991-01-31 GR GR91400101T patent/GR3001416T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7247987A (en) | 1987-11-05 |
| DE3767789D1 (de) | 1991-03-07 |
| PT84818B (pt) | 1989-12-29 |
| EP0251453B1 (en) | 1991-01-30 |
| PT84818A (en) | 1987-06-01 |
| AU600939B2 (en) | 1990-08-30 |
| NZ220179A (en) | 1989-10-27 |
| ES2031890T3 (es) | 1993-01-01 |
| EP0251453A2 (en) | 1988-01-07 |
| GB8610909D0 (en) | 1986-06-11 |
| EP0251453A3 (en) | 1988-09-28 |
| DK227487D0 (da) | 1987-05-04 |
| GR3001416T3 (en) | 1992-09-25 |
| JPS62267270A (ja) | 1987-11-19 |
| ZA873169B (en) | 1988-04-27 |
| US4861789A (en) | 1989-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK93887A (da) | Heterocycliske forbindelser | |
| DK321688D0 (da) | Heterocykliske forbindelser | |
| DK106786A (da) | Heterocycliske forbindelser | |
| FI96203C (fi) | Heterosyklisiä yhdisteitä | |
| DK517989D0 (da) | Heterocykliske forbindelser | |
| DK552685A (da) | Heterocycliske forbindelser | |
| DK162485D0 (da) | Heterocykliske forbindelser | |
| DK287688D0 (da) | Heterocycliske forbindelser | |
| DK219986D0 (da) | Nitrogenholdige heterocycliske forbindelser | |
| NO168305C (no) | Heterocykliske forbindelser | |
| DK227487A (da) | Substituerede heterocycliske forbindelser | |
| DK496086D0 (da) | Heterocykliske forbindelser | |
| DK64788D0 (da) | Heterocycliske forbindelser | |
| DK499987D0 (da) | Heterocycliske forbindelser | |
| DK496885D0 (da) | Heterocycliske forbindelser | |
| DK507289A (da) | Heterocykliske forbindelser | |
| DK429588A (da) | Heterocykliske forbindelser | |
| DK109586A (da) | Heterocycliske forbindelser | |
| DK397686A (da) | Heterocycliske forbindelser | |
| DK45887D0 (da) | Heterocykliske forbindelser | |
| DK343587A (da) | Acylerede heterocycliske forbindelser | |
| DK414886D0 (da) | Substituerede heterocycliske forbindelser | |
| DK565289A (da) | Heterocykliske forbindelser | |
| LV5744B4 (lv) | Heterocikliski savienojumi | |
| LV5743A4 (lv) | Heterocikliskie savienojumi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |